1. Home
  2. NEUP
  3. NEUP News

Latest Neuphoria Therapeutics Inc. (NEUP) News on November 28, 2025

Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value
NEUP

GlobeNewswire

17 days ago

Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value

Is Neuphoria Therapeutics Inc. (NASDAQ:NEUP) Worth US$4.4 Based On Its Intrinsic Value?
NEUP

Simply Wall St.

a month ago

Is Neuphoria Therapeutics Inc. (NASDAQ:NEUP) Worth US$4.4 Based On Its Intrinsic Value?

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process
NEUP

GlobeNewswire

a month ago

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process

NEUP

Associated Press Finance

a month ago

BC-Most Active Stocks

Neuphoria scraps social anxiety hopeful after Phase III miss
NEUP

Clinical Trials Arena

a month ago

Neuphoria scraps social anxiety hopeful after Phase III miss

NEUP

MT Newswires

a month ago

Top Midday Decliners

NEUP

MT Newswires

a month ago

Investors Parse Earnings Reports With US Equity Futures Flat Tuesday Pre-Bell

NEUP

MT Newswires

a month ago

Top Premarket Decliners

NEUP

MT Newswires

a month ago

Neuphoria Says Phase 3 Trial of BNC210 to Treat Social Anxiety Disorder Did Not Meet Primary Endpoint

Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder
NEUP

GlobeNewswire

a month ago

Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder

Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
NEUP

GlobeNewswire

6 months ago

Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting

Neuphoria Provides First Quarter 2025 Business Updates
NEUP

GlobeNewswire

6 months ago

Neuphoria Provides First Quarter 2025 Business Updates

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans
NEUP

GlobeNewswire

7 months ago

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025
NEUP

GlobeNewswire

9 months ago

Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck
NEUP

GlobeNewswire

10 months ago

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck

Share on Social Networks: